Why Shares of Solazyme Inc. Plunged Today

Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.

What: Shares of Solazyme Inc (NASDAQ: SZYM  ) fell as much as 10.6% today after the company reported first-quarter earnings.

So what: Revenue was up 85% to $12.4 million but net loss increased from $26.5 million a year ago to $34.7 million last quarter. Even on a non-GAAP basis, the loss of $30.5 million equated to $0.44 per share, which was much higher than the $0.33 loss analysts expected.

Now what: Solazyme has long been a company with a lot of promise, and management pointed to progress in Clinton/Galva, the encapsulated lubricant Encapso, and Algenist. But Solazyme isn't anywhere close to leading to a profit, and analysts have high expectations for the company this year and next. Analysts have estimated revenue of $115.2 million in 2014 and $330.4 million next year, so Solazyme needs to pick up production to keep investors happy, something it clearly didn't do fast enough in the first quarter.

Will this stock be your next multibagger?
The hope was that Solazyme could be a multibagger, but if you give me five minutes I'll show you how you could own the best stock for 2014. Every year, The Motley Fool's chief investment officer hand-picks one stock with outstanding potential. But it's not just any run-of-the-mill company. It's a stock perfectly positioned to cash in on one of the upcoming year's most lucrative trends. Last year his pick skyrocketed 134%. And previous top picks have gained upwards of 908%, 1,252% and 1,303% over the subsequent years! Believe me, you don't want to miss what could be his biggest winner yet! Just click here to download your free copy of "The Motley Fool's Top Stock for 2014" today.

Read/Post Comments (2) | Recommend This Article (3)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On May 07, 2014, at 3:43 PM, TMFBlacknGold wrote:

    I think most of the weakness post earnings stems from the delay at Moema (the 100,000 MT per year facility being commissioned in Brazil). Revenue and EPS misses/beats don't matter at this point.


  • Report this Comment On May 13, 2014, at 2:13 PM, Whamo wrote:

    I got into this stock today, perhaps I'm a little early, but I look forward to better days.

Add your comment.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2945796, ~/Articles/ArticleHandler.aspx, 9/3/2015 9:18:40 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Travis Hoium

Travis Hoium has been writing for since July 2010 and covers the solar industry, renewable energy, and gaming stocks among other things.

Today's Market

updated 12 hours ago Sponsored by:
DOW 16,351.38 293.03 0.00%
S&P 500 1,948.86 35.01 0.00%
NASD 4,749.98 0.00 0.00%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

9/2/2015 4:00 PM
SZYM $2.23 Down +0.00 +0.00%
Solazyme CAPS Rating: ***